Aurobindo Pharma Ltd.: Top and Latest News, Videos and Photos about Aurobindo Pharma Ltd.

Showing 14 results for

Molnupiravir is for treatment of adult patients hospitalised with Covid-19, under certain conditions, a press release from Aurobindo Pharma said.

Aurobindo Pharma introduces Covid-19 drug Molnupiravir in India

2 min read . Updated: 06 Jan 2022

Day trading guide for stock market today: Immediate support for NSE Nifty is placed at 16,830 levels, say experts. (PTI)

Day trading guide for Thursday: 6 stocks to buy or sell today — 23rd December

1 min read . Updated: 23 Dec 2021

There is no significant efficacy against moderate Covid and the effective efficacy is towards mild cases, a DCGI source said. (Reuters)

DCGI sees Merck drug less effective against moderate Covid: Report

1 min read . Updated: 08 Oct 2021

Asia's stocks fell to fresh seven-month troughs on Tuesday, led by a third straight session of heavy selling of Chinese internet giants, while bond and currency markets clung to tight ranges ahead of the Federal Reserve policy meeting (Mint)

Markets slip as healthcare, banking stocks drag

1 min read . Updated: 27 Jul 2021

In the long-term, whether the Zomato stock does well depends on how well the firm’s business model works out

Zomato raises ₹4,196 cr from anchor investors ahead of IPO

2 min read . Updated: 13 Jul 2021

Aurobindo Pharma on Monday reported a marginal decline in its net profit at Rs528.5 crore for the fourth quarter ended March 2018. Photo: Bloomberg

Aurobindo on firm ground but valuations reflect near-term gains

2 min read . Updated: 28 Dec 2020

FILE PHOTO: Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai, India June 17, 2015. REUTERS/Danish Siddiqui/File photo (REUTERS)

Cipla shares get a boost from Revlimid patent settlement

1 min read . Updated: 14 Dec 2020

Shares of IndiGo parent InterGlobe Aviation closed 10% higher on Wednesday.

Stocks to Watch: InterGlobe Aviation, Aurobindo Pharma, Tata Power, IT companies

2 min read . Updated: 13 Aug 2020

Aurobindo Pharma on Monday reported a marginal decline in its net profit at Rs528.5 crore for the fourth quarter ended March 2018. Photo: Bloomberg

Aurobindo Pharma’s unit IV gets a reprieve; focus on new filings

1 min read . Updated: 22 Apr 2020

Shares of Aurobindo Pharma plunged, ending down more than 20%. (Photo: Mint)

Regulatory concerns drag Glenmark, Aurobindo Pharma, Lupin shares to 52-week low

1 min read . Updated: 07 Oct 2019

×

Get alerts on WhatsApp

Set Preferences My Reads Feedback Redeem a Gift Card Logout